Citations (104)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (40)
Weimin Li, Sami Z Daoud, Roopa Trivedi, Pradeep B Lukka, Eulalia Jimenez, Eduard Molins, Catherine Stewart, Pranob Bharali & Esther Garcia-Gil. (2023) The Pharmacokinetics, Safety and Tolerability of Aclidinium Bromide 400 μg Administered by Inhalation as Single and Multiple (Twice Daily) Doses in Healthy Chinese Participants. International Journal of Chronic Obstructive Pulmonary Disease 18, pages 2725-2735.
Read now
Read now
Seon Cheol Park, Narongkorn Saiphoklang, Jonathan Phillips, May-Lin Wilgus, Russell G Buhr, Donald P Tashkin, Christopher B Cooper & Igor Barjaktarevic. (2023) Three-Month Variability of Commonly Evaluated Biomarkers in Clinically Stable COPD. International Journal of Chronic Obstructive Pulmonary Disease 18, pages 1475-1486.
Read now
Read now
Tanja Plate, Felix W Friedrich & Jutta Beier. (2020) Effectiveness and Tolerability of LABA/LAMA Fixed-Dose Combinations Aclidinium/Formoterol, Glycopyrronium/Indacaterol and Umeclidinium/Vilanterol in the Treatment of COPD in Daily Practice – Results of the Non-Interventional DETECT Study. International Journal of Chronic Obstructive Pulmonary Disease 15, pages 1335-1347.
Read now
Read now
Konstantinos Kostikas, Theodoros I Vassilakopoulos, Nikos Tzanakis, Athanasios K Konstantinidis, Epameinondas N Kosmas, Spyros Papiris, Paschalis Steiropoulos, Effrosyni D Manali, Stylianos A Michaelides & Grigorios Daskos. (2020) A Real-World Observational Study Examining the Impact of Aclidinium Bromide Therapy on the Quality of Life, Symptoms, and Activity Impairment of Patients with Chronic Obstructive Pulmonary Disease: The Greek ON-AIR Study. International Journal of Chronic Obstructive Pulmonary Disease 15, pages 515-526.
Read now
Read now
G. Hillas, A. Papaporfyriou, K. Dimakou & A. I. Papaioannou. (2020) Pharmacological treatment of stable COPD: need for a simplified approach. Postgraduate Medicine 132:2, pages 126-131.
Read now
Read now
Arzu Ari & James B Fink. (2020) Recent advances in aerosol devices for the delivery of inhaled medications. Expert Opinion on Drug Delivery 17:2, pages 133-144.
Read now
Read now
Jean Bourbeau, Mohit Bhutani, Paul Hernandez, Shawn D. Aaron, Meyer Balter, Marie-France Beauchesne, Anthony D’Urzo, Roger Goldstein, Alan Kaplan, François Maltais, Don D. Sin & Darcy D. Marciniuk. (2019) Canadian Thoracic Society Clinical Practice Guideline on pharmacotherapy in patients with COPD – 2019 update of evidence. Canadian Journal of Respiratory, Critical Care, and Sleep Medicine 3:4, pages 210-232.
Read now
Read now
Fuyuan Li & Junyi Yang. (2019) Revefenacin for the treatment of chronic obstructive pulmonary disease. Expert Review of Clinical Pharmacology 12:4, pages 293-298.
Read now
Read now
Edward Kerwin & Gary T. Ferguson. (2018) An overview of glycopyrrolate/eFlow® CS in COPD. Expert Review of Respiratory Medicine 12:6, pages 447-459.
Read now
Read now
Mario Malerba, Alessandro Radaeli, Giuseppe Santini, Jaymin Morjaria, Nadia Mores, Chiara Mondino, Giuseppe Macis & Paolo Montuschi. (2018) The discovery and development of aclidinium bromide for the treatment of chronic obstructive pulmonary disease. Expert Opinion on Drug Discovery 13:6, pages 563-577.
Read now
Read now
Mohamed Ismail Abdul Aziz, Ling Eng Tan, David Bin-Chia Wu, Fiona Pearce, Gerald Seng Wee Chua, Liang Lin, Ping-Tee Tan & Kwong Ng. (2018) Comparative efficacy of inhaled medications (ICS/LABA, LAMA, LAMA/LABA and SAMA) for COPD: a systematic review and network meta-analysis. International Journal of Chronic Obstructive Pulmonary Disease 13, pages 3203-3231.
Read now
Read now
Jean Bourbeau, Mohit Bhutani, Paul Hernandez, Darcy D. Marciniuk, Shawn D. Aaron, Meyer Balter, Marie-France Beauchesne, Anthony D'Urzo, Roger Goldstein, Alan Kaplan, François Maltais, Denis E. O'Donnell & Don D. Sin. (2017) CTS position statement: Pharmacotherapy in patients with COPD—An update. Canadian Journal of Respiratory, Critical Care, and Sleep Medicine 1:4, pages 222-241.
Read now
Read now
Mike Thomas, David MG Halpin & Marc Miravitlles. (2017) When is dual bronchodilation indicated in COPD?. International Journal of Chronic Obstructive Pulmonary Disease 12, pages 2291-2305.
Read now
Read now
Nicola A Hanania, Suzanne C. Lareau & Barbara P. Yawn. (2017) Safety of inhaled long-acting anti-muscarinic agents in COPD. Postgraduate Medicine 129:5, pages 500-512.
Read now
Read now
Amanda R. van Buul, Marise J. Kasteleyn, Niels H. Chavannes & Christian Taube. (2017) Morning symptoms in COPD: a treatable yet often overlooked factor. Expert Review of Respiratory Medicine 11:4, pages 311-322.
Read now
Read now
Jadwiga A. Wedzicha, Alvar Agusti, Gavin Donaldson, Ferran Chuecos, Rosa Lamarca & Esther Garcia Gil. (2016) Effect of Aclidinium Bromide on Exacerbations in Patients with Moderate-to-Severe COPD: A Pooled Analysis of Five Phase III, Randomized, Placebo-Controlled Studies. COPD: Journal of Chronic Obstructive Pulmonary Disease 13:6, pages 669-676.
Read now
Read now
Yong Zou, Jian Xiao, Dan Hui Yang, Jun Li & Qiong Chen. (2016) Efficacy and Safety of an Aclidinium Bromide Treatment for 12 Weeks or Longer in Patients with Moderate-To-Severe COPD: A Meta-Analysis. COPD: Journal of Chronic Obstructive Pulmonary Disease 13:4, pages 499-508.
Read now
Read now
Denis E. O’Donnell, Katherine A. Webb, Ingrid Harle & J. Alberto Neder. (2016) Pharmacological management of breathlessness in COPD: recent advances and hopes for the future. Expert Review of Respiratory Medicine 10:7, pages 823-834.
Read now
Read now
Marco Contoli, Paolo Solidoro, Fabiano Di Marco, Nicola Scichilone, Angelo Corsico, Fulvio Braido & Pierachille Santus. (2016) Effects of aclidinium on determinants of COPD severity: symptoms and quality of life. International Journal of Chronic Obstructive Pulmonary Disease 11, pages 3043-3050.
Read now
Read now
Thomas R. Einarson, Basil G. Bereza, T. Anders Nielsen, Jan Van Laer & Michiel E. H. Hemels. (2016) Systematic review of models used in economic analyses in moderate-to-severe asthma and COPD. Journal of Medical Economics 19:4, pages 319-355.
Read now
Read now
Jose Luis Lopez-Campos, Carmen Calero, Cecilia Lopez-Ramirez, Maria Isabel Asensio-Cruz, Eduardo Márquez-Martín & Francisco Ortega-Ruiz. (2015) Patient-reported outcomes and considerations in the management of COPD: focus on aclidinium. Patient Preference and Adherence 9, pages 95-104.
Read now
Read now
Subhabrata Moitra, Arvind B Bhome & Bill B Brashier. (2015) Aclidinium bromide/formoterol fixed-dose combination therapy for COPD: the evidence to date. Drug Design, Development and Therapy 9, pages 1989-1999.
Read now
Read now
DP Tashkin. (2015) The safety of anticholinergic bronchodilators for the treatment of chronic obstructive pulmonary disease. Expert Opinion on Drug Safety 14:11, pages 1759-1772.
Read now
Read now
Tony D’Urzo, James F Donohue, David Price, Marc Miravitlles & Edward Kerwin. (2015) Dual bronchodilator therapy with aclidinium bromide/formoterol fumarate for chronic obstructive pulmonary disease. Expert Review of Respiratory Medicine 9:5, pages 519-532.
Read now
Read now
Andrea S Melani. (2015) Long-acting muscarinic antagonists. Expert Review of Clinical Pharmacology 8:4, pages 479-501.
Read now
Read now
Afisi Segun Ismaila, Eline L Huisman, Yogesh Suresh Punekar & Andreas Karabis. (2015) Comparative efficacy of long-acting muscarinic antagonist monotherapies in COPD: a systematic review and network meta-analysis. International Journal of Chronic Obstructive Pulmonary Disease 10, pages 2495-2517.
Read now
Read now
Igor Z Barjaktarevic, Anthony F Arredondo & Christopher B Cooper. (2015) Positioning new pharmacotherapies for COPD. International Journal of Chronic Obstructive Pulmonary Disease 10, pages 1427-1442.
Read now
Read now
Paul W Jones. (2015) Clinical potential of aclidinium bromide in chronic obstructive pulmonary disease. International Journal of Chronic Obstructive Pulmonary Disease 10, pages 677-687.
Read now
Read now
Chitra Lal & Charlie Strange. (2015) Aclidinium bromide plus formoterol for the treatment of chronic obstructive pulmonary disease. Expert Opinion on Pharmacotherapy 16:3, pages 427-434.
Read now
Read now
Andreas Karabis, Michelle Mocarski, Indra Eijgelshoven & Gert Bergman. (2014) Economic evaluation of aclidinium bromide in the management of moderate to severe COPD: an analysis over 5 years. ClinicoEconomics and Outcomes Research 6, pages 175-185.
Read now
Read now
Debra J Reid & Alexa A Carlson. (2014) Clinical use of aclidinium in patients with COPD. International Journal of Chronic Obstructive Pulmonary Disease 9, pages 369-379.
Read now
Read now
Emily M. Armstrong, Bradley M. Wright, Allison Meyer, Courtney S. Watts & Kristi W. Kelley. (2014) The Role of Aclidinium Bromide in the Treatment of Chronic Obstructive Pulmonary Disease. Hospital Practice 42:4, pages 99-110.
Read now
Read now
Nicolas Roche, Mark Small, Sarah Broomfield, Victoria Higgins & Ryan Pollard. (2013) Real World COPD: Association of Morning Symptoms with Clinical and Patient Reported Outcomes. COPD: Journal of Chronic Obstructive Pulmonary Disease 10:6, pages 679-686.
Read now
Read now
Jutta Beier, Anne-Marie Kirsten, Robert Mróz, Rosa Segarra, Ferran Chuecos, Cynthia Caracta & Esther Garcia Gil. (2013) Efficacy and Safety of Aclidinium Bromide Compared with Placebo and Tiotropium in Patients with Moderate-to-Severe Chronic Obstructive Pulmonary Disease: Results from a 6-week, Randomized, Controlled Phase Iiib Study. COPD: Journal of Chronic Obstructive Pulmonary Disease 10:4, pages 511-522.
Read now
Read now
Anthony D’Urzo, Edward Kerwin, Stephen Rennard, Thomas He, Esther Garcia Gil & Cynthia Caracta. (2013) One-Year Extension Study of ACCORD COPD I: Safety and Efficacy of Two Doses of Twice-daily Aclidinium Bromide in Patients with COPD. COPD: Journal of Chronic Obstructive Pulmonary Disease 10:4, pages 500-510.
Read now
Read now
Andreas Karabis, Leandro Lindner, Michelle Mocarski, Eline Huisman & Andrew Greening. (2013) Comparative efficacy of aclidinium versus glycopyrronium and tiotropium, as maintenance treatment of moderate to severe COPD patients: a systematic review and network meta-analysis. International Journal of Chronic Obstructive Pulmonary Disease 8, pages 405-423.
Read now
Read now
Jose Luis Lopez-Campos, Carmen Calero & Esther Quintana-Gallego. (2013) Symptom variability in COPD: a narrative review. International Journal of Chronic Obstructive Pulmonary Disease 8, pages 231-238.
Read now
Read now
Mario Cazzola, Clive P Page & Maria Gabriella Matera. (2013)
Aclidinium bromide for the treatment of chronic obstructive pulmonary disease. Expert Opinion on Pharmacotherapy 14:9, pages 1205-1214.
Read now
Read now
Vandana Gupta & Dave Singh. (2012) Aclidinium bromide for the treatment of chronic obstructive pulmonary disease. Expert Review of Respiratory Medicine 6:6, pages 581-588.
Read now
Read now
Anthony D'Urzo & Claus Vogelmeier. (2012) Future of chronic obstructive pulmonary disease management. Expert Review of Respiratory Medicine 6:3, pages 285-299.
Read now
Read now
Articles from other publishers (64)
Luigino Calzetta, Beatrice Ludovica Ritondo, Maria Cristina Zappa, Gian Marco Manzetti, Andrea Perduno, Janis Shute & Paola Rogliani. (2022) The impact of long-acting muscarinic antagonists on mucus hypersecretion and cough in chronic obstructive pulmonary disease: a systematic review. European Respiratory Review 31:164, pages 210196.
Crossref
Crossref
Elena Rivero-Ferrer, Morten Olesen, Estel Plana, Jaume Aguado, Núria Saigí-Morgui, Annalisa Rubino, Sami Z. Daoud, Alejhandra Lei, Susana Perez-Gutthann, Tania Schink, Nina Sahlertz Kristiansen, Jesper Hallas, Anton Pottegård & Cristina Rebordosa. (2022) Characteristics of New Users of Aclidinium Bromide, Aclidinium/Formoterol, and Other COPD Medications in the United Kingdom, Denmark, and Germany. Clinical Drug Investigation 42:4, pages 319-331.
Crossref
Crossref
Yasuhito Suzuki, Suguru Sato, Kento Sato, Sumito Inoue & Yoko Shibata. (2022) Treatment efficacy of LAMA versus placebo for stable chronic obstructive pulmonary disease: A systematic review and meta-analysis. Respiratory Investigation 60:1, pages 108-118.
Crossref
Crossref
Kritika Laxmikeshav, Pooja Kumari & Nagula Shankaraiah. (2021) Expedition of sulfur‐containing heterocyclic derivatives as cytotoxic agents in medicinal chemistry: A decade update. Medicinal Research Reviews 42:1, pages 513-575.
Crossref
Crossref
Nicolle J. Domnik, Matthew D. James, Robin E. Scheeren, Grace A. Ayoo, Sarah M. Taylor, Amanda T. Di Luch, Kathryn M. Milne, Sandra G. Vincent, Devin B. Phillips, Amany F. Elbehairy, Sophie J. Crinion, Helen S. Driver, J. Alberto Neder & Denis E. O’Donnell. (2021) Deterioration of Nighttime Respiratory Mechanics in COPD. Chest 159:1, pages 116-127.
Crossref
Crossref
Stefan-Marian Frent. 2020. Update in Respiratory Diseases. Update in Respiratory Diseases.
Lowie EGW Vanfleteren, Bianca Beghe, Anders Andersson, Daniel Hansson, Leonardo M Fabbri & Ludger Grote. (2020) Multimorbidity in COPD, does sleep matter?. European Journal of Internal Medicine 73, pages 7-15.
Crossref
Crossref
Ioanna Tsiligianni & Janwillem W. H. Kocks. (2020) Daytime symptoms of chronic obstructive pulmonary disease: a systematic review. npj Primary Care Respiratory Medicine 30:1.
Crossref
Crossref
Walter T. McNicholas, Daniel Hansson, Sofia Schiza & Ludger Grote. (2019) Sleep in chronic respiratory disease: COPD and hypoventilation disorders. European Respiratory Review 28:153, pages 190064.
Crossref
Crossref
Z. R. Aisanov, A. G. Chuchalin & E. N. Kalmanova. (2019) Chronic obstructive pulmonary disease and cardiovascular comorbidity. Kardiologiia 59:8S, pages 24-36.
Crossref
Crossref
S N Avdeev & N V Trushenko. (2019) New opportunities of dual bronchodilation therapy for patients with chronic obstructive pulmonary disease. Terapevticheskii arkhiv 91:3, pages 76-85.
Crossref
Crossref
Yuji Oba, Edna Keeney, Namratta Ghatehorde & Sofia Dias. (2018) Dual combination therapy versus long-acting bronchodilators alone for chronic obstructive pulmonary disease (COPD): a systematic review and network meta-analysis. Cochrane Database of Systematic Reviews 2018:12.
Crossref
Crossref
Yong Suk Jo, Sangshin Park, Deog Kyeom Kim, Chul-Gyu Yoo & Chang-Hoon Lee. (2018) The cutoff point of clinical chronic obstructive pulmonary disease questionnaire for more symptomatic patients. BMC Pulmonary Medicine 18:1.
Crossref
Crossref
David M. G. Halpin. (2018) The Role of Tiotropium+Olodaterol Dual Bronchodilator Therapy in the Management of Chronic Obstructive Pulmonary Disease. Tuberculosis and Respiratory Diseases 81:1, pages 13.
Crossref
Crossref
Lindsay G.S. Bengtson, Michael DePietro, Jeffrey McPheeters & Kathleen M. Fox. (2018) Real-world outcomes in patients with chronic obstructive pulmonary disease initiating long-acting mono bronchodilator therapy. Therapeutic Advances in Respiratory Disease 12, pages 175346661877275.
Crossref
Crossref
Marc Miravitlles, Antonio Anzueto & José R. Jardim. (2017) Optimizing bronchodilation in the prevention of COPD exacerbations. Respiratory Research 18:1.
Crossref
Crossref
F. Blasi, G. W. Canonica & M. Miravitlles. (2017) Is aclidinium alone or combined with a LABA a rational choice for symptomatic COPD patients?. Respiratory Research 18:1.
Crossref
Crossref
Nicolas Roche, Kenneth R. Chapman, Claus F. Vogelmeier, Felix J. F. Herth, Chau Thach, Robert Fogel, Petter Olsson, Francesco Patalano, Donald Banerji & Jadwiga A. Wedzicha. (2017) Blood Eosinophils and Response to Maintenance Chronic Obstructive Pulmonary Disease Treatment. Data from the FLAME Trial. American Journal of Respiratory and Critical Care Medicine 195:9, pages 1189-1197.
Crossref
Crossref
Fabio Arpinelli, Mauro Carone, Gioacchino Riccardo & Giorgio Bertolotti. (2016) Health-related quality of life measurement in asthma and chronic obstructive pulmonary disease: review of the 2009-2014 literature. Multidisciplinary Respiratory Medicine 11:1.
Crossref
Crossref
Sara Roversi, Leonardo M. Fabbri, Don D. Sin, Nathaniel M. Hawkins & Alvar Agustí. (2016) Chronic Obstructive Pulmonary Disease and Cardiac Diseases. An Urgent Need for Integrated Care. American Journal of Respiratory and Critical Care Medicine 194:11, pages 1319-1336.
Crossref
Crossref
James F. Donohue, Weily Soong, Xiao Wu, Pomy Shrestha & Alejhandra Lei. (2016) Long-term safety of aclidinium bromide/formoterol fumarate fixed-dose combination: Results of a randomized 1-year trial in patients with COPD. Respiratory Medicine 116, pages 41-48.
Crossref
Crossref
Rainard Fuhr, Anne Leselbaum & Jordi Aubets. (2016) Pharmacokinetics of aclidinium bromide/formoterol fumarate fixed-dose combination compared with individual components: A phase 1, open-label, single-dose study. Clinical Pharmacology in Drug Development 5:2, pages 109-117.
Crossref
Crossref
Mitsuhiro Yamada & Masakazu Ichinose. (2015) Cutting edge of COPD therapy: current pharmacological therapy and future direction. COPD Research and Practice 1:1.
Crossref
Crossref
Amadeu Gavald?Elena Gabarda, Javier Milara, Julio Cortijo, Esteban Morcillo, Jorge Beleta & Montserrat Miralpeix. (2015) Pharmacological Assessment of the In Vitro Functional Selectivity of Aclidinium Bromide at M3 and M2 Muscarinic Receptors in Human Tissue. Pulmonary Therapy 1:1, pages 103-107.
Crossref
Crossref
Sang Haak Lee, Jongmin Lee, Kwang Ha Yoo, Soo‐Taek Uh, Myung Jae Park, Sang Yeub Lee, Jae Yeol Kim, Deog Kyeom Kim, Seung Joon Kim, Kwan Ho Lee & Chul‐Gyu Yoo. (2015)
Efficacy and safety of aclidinium bromide in patients with
COPD
: A phase 3 randomized clinical trial in a
K
orean population
. Respirology 20:8, pages 1222-1228.
Crossref
Crossref
Jutta Beier. (2015) A twice-daily, fixed-dose combination of aclidinium bromide and formoterol fumarate for the treatment of chronic obstructive pulmonary disease. Clinical Investigation 5:8, pages 691-700.
Crossref
Crossref
Paul W. Jones. (2015) Long-acting muscarinic antagonists for the prevention of exacerbations of chronic obstructive pulmonary disease. Therapeutic Advances in Respiratory Disease 9:3, pages 84-96.
Crossref
Crossref
Guy F. Joos, Joseph-Leon Aumann, Carl Coeck, Lawrence Korducki, Alan L. Hamilton, Christina Kunz & René Aalbers. (2015) A randomised, double-blind, four-way, crossover trial comparing the 24-h FEV1 profile for once-daily versus twice-daily treatment with olodaterol, a novel long-acting β2-agonist, in patients with chronic obstructive pulmonary disease. Respiratory Medicine 109:5, pages 606-615.
Crossref
Crossref
Katharina Marth, Elisabeth Schuller & Wolfgang Pohl. (2015) Improvements in patient-reported outcomes: A prospective, non-interventional study with aclidinium bromide for treatment of COPD. Respiratory Medicine 109:5, pages 616-624.
Crossref
Crossref
K. Suresh Babu & Jaymin B. Morjaria. (2015) Clinicopharmacological profile of the fixed-dose combination of aclidinium bromide and formoterol fumarate in the management of chronic obstructive pulmonary disease. Therapeutic Advances in Respiratory Disease 9:2, pages 56-68.
Crossref
Crossref
Christopher M. Jones & Lucy M.R. Nell. (2015) Adverse reactions to anticholinergic agents used in the management of obstructive pulmonary disease. Adverse Drug Reaction Bulletin 291:1, pages 1123-1126.
Crossref
Crossref
Yuji Oba & Nazir A. Lone. (2015) Comparative efficacy of long-acting muscarinic antagonists in preventing COPD exacerbations: a network meta-analysis and meta-regression. Therapeutic Advances in Respiratory Disease 9:1, pages 3-15.
Crossref
Crossref
Donald A. Mahler & Denis E. O'Donnell. (2015) Recent Advances in Dyspnea. Chest 147:1, pages 232-241.
Crossref
Crossref
Anthony D D’Urzo, Stephen I Rennard, Edward M Kerwin, Victor Mergel, Anne R Leselbaum & Cynthia F Caracta. (2014) Efficacy and safety of fixed-dose combinations of aclidinium bromide/formoterol fumarate: the 24-week, randomized, placebo-controlled AUGMENT COPD study. Respiratory Research 15:1.
Crossref
Crossref
Kai M Beeh, Henrik Watz, Luis Puente-Maestu, Luis de Teresa, Diana Jarreta, Cynthia Caracta, Esther Garcia Gil & Helgo Magnussen. (2014) Aclidinium improves exercise endurance, dyspnea, lung hyperinflation, and physical activity in patients with COPD: a randomized, placebo-controlled, crossover trial. BMC Pulmonary Medicine 14:1.
Crossref
Crossref
Dave Singh, Paul W Jones, Eric D Bateman, Stephanie Korn, Cristina Serra, Eduard Molins, Cynthia Caracta, Esther Garcia Gil & Anne Leselbaum. (2014) Efficacy and safety of aclidinium bromide/formoterol fumarate fixed-dose combinations compared with individual components and placebo in patients with COPD (ACLIFORM-COPD): a multicentre, randomised study. BMC Pulmonary Medicine 14:1.
Crossref
Crossref
Han Ni, Zay Soe & Soe Moe. (2014) Aclidinium bromide for stable chronic obstructive pulmonary disease. Cochrane Database of Systematic Reviews 2015:4.
Crossref
Crossref
Amadeu Gavaldà, Israel Ramos, Carla Carcasona, Elena Calama, Raquel Otal, José Luis Montero, Sonia Sentellas, Monica Aparici, Dolors Vilella, Joan Alberti, Jorge Beleta & Montserrat Miralpeix. (2014) The in vitro and in vivo profile of aclidinium bromide in comparison with glycopyrronium bromide. Pulmonary Pharmacology & Therapeutics 28:2, pages 114-121.
Crossref
Crossref
Etzel Gysling. (2014) Aclidinium. pharma-kritik 36:5.
Crossref
Crossref
Anthony D D'Urzo, M Reza Maleki-Yazdi & R Andrew McIvor. (2014) Evolving therapies in chronic obstructive pulmonary disease. Clinical Practice 11:3, pages 307-325.
Crossref
Crossref
Kayleigh M Kew, Sofia Dias & Christopher J Cates. (2014) Long-acting inhaled therapy (beta-agonists, anticholinergics and steroids) for COPD: a network meta-analysis. Cochrane Database of Systematic Reviews.
Crossref
Crossref
L. E. Stone, J. W. Skelley, J. A. Kyle & L. K. Elmore. (2014) Aclidinium bromide for the treatment of chronic obstructive pulmonary disease. American Journal of Health-System Pharmacy 71:5, pages 386-393.
Crossref
Crossref
Khuder Alagha, Alain Palot, Tunde Sofalvi, Laurie Pahus, Marion Gouitaa, Celine Tummino, Stephanie Martinez, Denis Charpin, Arnaud Bourdin & Pascal Chanez. (2014) Long-acting muscarinic receptor antagonists for the treatment of chronic airway diseases. Therapeutic Advances in Chronic Disease 5:2, pages 85-98.
Crossref
Crossref
David Domínguez-Fandos, Elisabet Ferrer, Raquel Puig-Pey, Cristina Carreño, Neus Prats, Mònica Aparici, Melina Mara Musri, Amadeu Gavaldà, Víctor I. Peinado, Montserrat Miralpeix & Joan A. Barberà. (2014) Effects of Aclidinium Bromide in a Cigarette Smoke–Exposed Guinea Pig Model of Chronic Obstructive Pulmonary Disease. American Journal of Respiratory Cell and Molecular Biology 50:2, pages 337-346.
Crossref
Crossref
Alexander G. Mathioudakis, Victoria Chatzimavridou-Grigoriadou & Georgios A. Mathioudakis. 2014. A worldwide yearly survey of new data in adverse drug reactions. A worldwide yearly survey of new data in adverse drug reactions
241
256
.
Asha Hareendran, Andrew C Palsgrove, Michelle Mocarski, Michael L Schaefer, Juliana Setyawan, Robyn Carson & Barry Make. (2013) The development of a patient-reported outcome measure for assessing nighttime symptoms of chronic obstructive pulmonary disease. Health and Quality of Life Outcomes 11:1.
Crossref
Crossref
Arthur F. Gelb, Donald P. Tashkin, Barry J. Make, Xiaoyun Zhong, Esther Garcia Gil & Cynthia Caracta. (2013) Long-term safety and efficacy of twice-daily aclidinium bromide in patients with COPD. Respiratory Medicine 107:12, pages 1957-1965.
Crossref
Crossref
Stephen I. Rennard, Paul D. Scanlon, Gary T. Ferguson, Ludmyla Rekeda, Brian T. Maurer, Esther Garcia Gil & Cynthia F. Caracta. (2013) ACCORD COPD II: A Randomized Clinical Trial to Evaluate the 12-Week Efficacy and Safety of Twice-Daily Aclidinium Bromide in Chronic Obstructive Pulmonary Disease Patients. Clinical Drug Investigation 33:12, pages 893-904.
Crossref
Crossref
A. Prakash, K.S. Babu & J.B. Morjaria. (2013) Novel anti-cholinergics in COPD. Drug Discovery Today 18:21-22, pages 1117-1126.
Crossref
Crossref
J Andrew Woods, Kimberly L Nealy & Robert W Barrons. (2013) Aclidinium Bromide: An Alternative Long-Acting Inhaled Anticholinergic in the Management of Chronic Obstructive Pulmonary Disease. Annals of Pharmacotherapy 47:7-8, pages 1017-1028.
Crossref
Crossref
Jos? Luis L?pez-Campos. (2013) Interacci?n M2-?2: bases para el tratamiento broncodilatador combinado. Archivos de Bronconeumolog?a 49:7, pages 279-281.
Crossref
Crossref
Jos? Luis L?pez-Campos. (2013) M2??2 Interaction: A Basis for Combined Bronchodilator Treatment. Archivos de Bronconeumolog?a (English Edition) 49:7, pages 279-281.
Crossref
Crossref
Mario Cazzola, Clive Page & Maria Gabriella Matera. (2013) Long-acting muscarinic receptor antagonists for the treatment of respiratory disease. Pulmonary Pharmacology & Therapeutics 26:3, pages 307-317.
Crossref
Crossref
Paul Jones. (2013) Aclidinium Bromide Twice Daily for the Treatment of Chronic Obstructive Pulmonary Disease: A Review. Advances in Therapy 30:4, pages 354-368.
Crossref
Crossref
Donald P Tashkin. (2013) Tiotropium for the treatment of chronic obstructive pulmonary disease. Clinical Practice 10:2, pages 141-155.
Crossref
Crossref
Lesley J. Scott, Katherine A. Lyseng-Williamson & James E. Frampton. (2013) Aclidinium: a guide to its use in chronic obstructive pulmonary disease in the EU. Drugs & Therapy Perspectives 29:2, pages 34-39.
Crossref
Crossref
Debra J. ReidNga T. Pham. (2013) Emerging Therapeutic Options for the Management of COPD. Clinical Medicine Insights: Circulatory, Respiratory and Pulmonary Medicine 7, pages CCRPM.S8140.
Crossref
Crossref
Stan EjioforAlice M. Turner. (2013) Pharmacotherapies for COPD. Clinical Medicine Insights: Circulatory, Respiratory and Pulmonary Medicine 7, pages CCRPM.S7211.
Crossref
Crossref
Dheeraj Gupta, Ritesh Agarwal, AshutoshNath Aggarwal, VN Maturu, Sahajal Dhooria, KT Prasad, InderpaulS Sehgal, LakshmikantB Yenge, Aditya Jindal, Navneet Singh, AG Ghoshal, GC Khilnani, JK Samaria, SN Gaur & D Behera. (2013) Guidelines for diagnosis and management of chronic obstructive pulmonary disease: Joint ICS/NCCP (I) recommendations. Lung India 30:3, pages 228.
Crossref
Crossref
Nicolas Roche, Niels H Chavannes & Marc Miravitlles. (2013) COPD symptoms in the morning: impact, evaluation and management. Respiratory Research 14:1, pages 112.
Crossref
Crossref
Joanne Bronson, Amelia Black, T. G. Murali Dhar, Bruce A. Ellsworth & J. Robert Merritt. 2013.
471
546
.
François Maltais & Julie Milot. (2012) The potential for aclidinium bromide, a new anticholinergic, in the management of chronic obstructive pulmonary disease. Therapeutic Advances in Respiratory Disease 6:6, pages 345-361.
Crossref
Crossref
James E. Frampton. (2012) Aclidinium. Drugs 72:15, pages 1999-2011.
Crossref
Crossref
K. Lasseter, S. Dilzer, J.M. Jansat, E. Garcia Gil, C.F. Caracta & S. Ortiz. (2012) Safety and pharmacokinetics of multiple doses of aclidinium bromide administered twice daily in healthy volunteers. Pulmonary Pharmacology & Therapeutics 25:2, pages 193-199.
Crossref
Crossref